ペンニードル（ペン型注入器用注射針）の世界市場：標準型ペンニードル、安全型ペンニードル、針長別分析、療法別分析...市場調査レポートについてご紹介

Table Of Contents

1 Introduction 15
1.1 Objectives Of The Study 15
1.2 Market Scope 15
1.3 Markets Covered 16
1.4 Stakeholders 17
1.5 Limitations 17

2 Research Methodology 18
2.1 Secondary And Primary Research Methodology 18
2.1.1 Secondary Research 18
2.1.2 Key Data From Secondary Sources 19
2.1.3 Primary Research 20
2.1.4 Key Industry Insights 20
2.1.4.1 Supply Side 20
2.1.4.2 Demand Side 21
2.1.5 Key Data From Primary Sources 22
2.1.6 Key Insights From Primary Sources 23
2.1.7 Market Size Estimation Methodology 23
2.1.8 Market Forecast Methodology 25
2.1.9 Market Data Validation And Data Triangulation 25
2.1.10 Assumptions 26

3 Executive Summary 27

4 Premium Insights 31
4.1 Asia To Be The Fastest-Growing Region In The Pen Needles Market 31
4.2 Pen Needles Market, By Region And Therapy 32
4.3 Geographical Snapshot 33
4.4 Pen Needles Market, By Type 33

5 Market Overview 34
5.1 Introduction 35
5.2 Market Segmentation 35
5.3 Market Dynamics 36
5.3.1 Drivers 36
5.3.1.1 Favorable Reimbursement Environment In North America & Europe 36
5.3.1.2 Strong Government Support In The Pacific 36
5.3.1.3 Advantages Of Insulin Pens Over Syringes And Vials 37
5.3.1.4 Technological Advancements 37
5.3.1.5 Entry Of Companies Into The Pen Needles Market 37
5.3.1.6 Growing Diabetic Population 38
5.3.1.7 Awareness Campaigns/Conferences 39
5.3.2 Restraints 40
5.3.2.1 Poor Reimbursement Structure In Developing Countries 40
5.3.2.2 Needle Anxiety 40
5.3.2.3 Severe Shortage Of Endocrinologists In The U.S. 40
5.3.3 Threats 41
5.3.3.1 Risk Involved In Reusing Pen Needles 41
5.3.3.2 Alternative Drug Delivery Methods 41
5.3.4 Opportunities 42
5.3.4.1 Safety Needles 42
5.3.4.2 Glp-1 Analogs 43
5.3.5 Challenges 43
5.3.5.1 Minimizing The Reuse Of Standard Pen Needles 43
5.3.5.2 Conservatism Towards Adoption Of Pen Injectors 44
5.3.6 Trends 44
5.3.6.1 Shorter & Higher-Gauge Needles 44
5.3.6.2 Easy-To-Fit Needles 44

6 Industry Insights 45
6.1 Porter’S Five Forces Analysis 45
6.1.1 Threat Of New Entrants 45
6.1.2 Supplier’S Bargaining Power 46
6.1.3 Buyer’S Bargaining Power 46
6.1.4 Segment Rivalry 46
6.1.5 Threat Of Substitutes 47
6.2 Competitive Intensity 47
6.2.1 Evaluation Parameters And Scores 47
6.2.2 Scoring Methodology 48
6.2.3 Competitive Intensity Score, By Company 49
6.2.3.1 Competitive Intensity Score For Bd 49
6.2.3.1 Competitive Intensity Score For Novo Nordisk 50
6.2.3.2 Competitive Intensity Score For Ypsomed 53
6.2.4 Competitive Intensity Mapping Of Bd, Novo Nordisk, And Ypsomed 54
6.2.5 Comparison Of Evaluation Parameters,By Company 56
6.2.5.1 Pricing 56
6.2.5.2 Product Portfolio 57
6.2.5.3 Product Launches/Technological Advancements 58
6.2.5.4 Production Capacity (2013) 58
6.2.5.5 Geographic Presence 59
6.2.5.6 Promotional/Marketing Activities 60
6.2.5.7 Sponsorship/Donations/Education/Awareness Campaigns 61
6.2.5.8 M&A, Partnerships, Collaborations, Agreements, And Expansion 61
6.2.5.9 Years Of Experience 62
6.2.5.10 Certifications/Accreditations/Awards 63
6.3 Pen Needles Market: Empirical Assessment Of Growth Strategies 63
6.3.1.1 Route To Strategic Growth: Organic And Inorganic Growth Strategies 64
6.3.1.2 Organic Growth Strategies 65
6.3.1.3 Inorganic Growth Strategies 65

7 Pen Needles Market, By Type 67
7.1 Introduction 68
7.2 Standard Pen Needles 71
7.3 Safety Pen Needles 75

8 Pen Needles Market, By Length 80
8.1 Introduction 81

9 Pen Needles Market, By Therapy 85
9.1 Introduction 86
9.2 Insulin 87
9.3 Glucagon-Like Peptide-1 (Glp-1) 88
9.4 Growth Hormones 89

10 Pen Needles Market, By Geography 90
10.1 Introduction 91
10.2 North America 92
10.2.1 U.S. 95
10.2.1.1 Growing Diabetes Prevalence Coupled With Reimbursement For Pen Needles To Boost Market 95
10.2.1.2 Federal Initiatives To Create Awareness About Injection Techniques To Stimulate U.S. Market 95
10.2.1.3 Increasing Activities Of Leading Players To Penetrate The U.S. Market To Push The Sales In The Region 96
10.2.1.4 Improved Pen Needle Technologies To Eliminate Needlestick Injuries To Fuel Market Growth 96
10.2.1.5 Low Penetration Of Pen Injectors In U.S. As Compared To Europe 97
10.2.2 Canada 98
10.2.2.1 High Diabetes Prevalence And Reimbursement For Pen Needles To Boost Market 98
10.2.2.2 Government Support In Alberta To Increase Usage Of Pen Needles In The Region 98
10.3 Europe 99
10.3.1 Germany 102
10.3.1.1 Regulatory Framework To Minimize Needlestick Injuries & Boost Use Of Safety-Engineered Devices 102
10.3.1.2 High Diabetes Prevalence And Reimbursement For Pen Needles To Accelerate German Market 103
10.3.2 U.K. 104
10.3.2.1 Activities To Pool Funds For Diabetes Care & Research To Stimulate Use Of Pen Needles 104
10.3.3 France 106
10.3.3.1 Conferences And Exhibitions To Increase Exposure For Pen Needles Players In French Market 106
10.3.3.2 Higher Insurance Coverage, Increase In Aging Population And Affordability Driving Market In France 106
10.3.4 Italy 107
10.3.4.1 Wide Regional Variations In Terms Of Benefits And Coverage To Drive Slow Growth In Italy 107
10.3.4.2 Awareness Campaigns For Diabetes In Italy To Propel The Market Growth 107
10.3.5 Spain 109
10.3.5.1 Spain Is Amongst The Top 10 Countries With Highest Expenditure On Diabetes 109
10.3.5.2 Spain Is Highly Active In Terms Of Exports Of Injectable Drug Delivery Devices 109
10.3.6 Rest Of Europe 111
10.3.6.1 High Diabetes Prevalence In Russia, Turkey, Poland, Romania, And Ukraine To Propel The Market For Pen Needles 111
10.4 Asia 112
10.4.1 Japan 115
10.4.1.1 High Adoption Of Insulin Pens And Approval Of Injectable Insulin To Fuel Market 115
10.4.2 China 116
10.4.2.1 Growing Presence Of Global Players In China To Boost The Market 116
10.4.2.2 High Diabetes Incidence And Adoption Of Insulin Pens To Stimulate The Market In China 116
10.4.2.3 Low Penetration Of Insulin Pens, High Re-Usage Rate & Lack Of Reimbursement To Limit Market Growth 117
10.4.3 India 118
10.4.3.1 Growing Presence Of Global Players In India To Propel The Market 118
10.4.3.2 Rising Diabetes Incidence To Stimulate The Market In India 118
10.4.4 Rest Of Asia 119
10.4.4.1 Vietnam A Potential Market For Pen Needles 119
10.4.4.2 Singapore & Malaysia Likely To Showcase Increase In Adoption Of Pen Needles Market 120
10.5 Rest Of The World (Row) 121
10.5.1 Latin America 123
10.5.2 Pacific Countries 124
10.5.3 Middle East & Africa 125
 
11 Competitive Landscape 126
11.1 Overview 126
11.2 Market Share Analysis, Pen Needles Market 127
11.2.1 Introduction 127
11.2.1.1 Becton, Dickinson And Company (U.S.) 127
11.2.1.2 Novo Nordisk A/S (Denmark) 130
11.2.1.3 Ypsomed Holding Ag (Switzerland) 131
11.2.1.4 Others 133
11.3 Competitive Situation And Trends 133
11.3.1 Expansions 134
11.3.2 New Product Launches 135
11.3.3 Acquisitions 136
11.3.4 Others 136

12 Company Profiles 138
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 Becton, Dickinson And Company 139
12.2 Novo Nordisk A/S 143
12.3 Ypsomed Holding Ag 146
12.4 Allison Medical, Inc. 149
12.5 Artsana S.P.A. 151
12.6 B. Braun Melsungen 152
12.7 Htl-Strefa S.A. 154
12.8 Owen Mumford, Ltd. 156
12.9 Terumo Corporation 158
12.10 Ultimed, Inc. 161
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

13 Appendix 163
13.1 Discussion Guide 163
13.2 Introducing Rt: Real-Time Market Intelligence 166
13.3 Available Customizations 167
13.4 Related Reports 168